CALCULATE YOUR SIP RETURNS

Concord Drugs Ltd Share Price Live

83.01

-1.33(1.58%)

Live Concord Drugs Share Price Chart

Concord Drugs Performance

Days Range

Previous Close₹84.34
Open₹86.03
Volume2,339
Day's Range₹82.27 - ₹86.03
52W Range₹26.10 - ₹92.52
Market Cap₹84.34 Cr

Concord Drugs Fundamentals

ROCE(TTM)6.00
P/E Ratio (TTM)145.41
P/B Ratio2.45
Industry P/E33.34
Debt to Equity0.5
ROE1.67
EPS (TTM)0.58
Dividend Yield0
Book Value34.42
Face Value10
ROCE(TTM)6.00
P/E Ratio (TTM)145.41
P/B Ratio2.45
Industry P/E33.34
Debt to Equity0.5
ROE1.67
EPS (TTM)0.58
Dividend Yield0
Book Value34.42
Face Value10

Concord Drugs Financials

Dec 2024Mar 2025Jun 2025Sep 2025
Net Sales10.8010.3913.6110.28
Expenses9.789.7312.969.52
Profit before tax0.530.060.160.27
Operating Profit0.230.040.120.19
Net Profit0.230.040.120.19
ESP in Rs0.230.040.120.19

Concord Drugs Shareholding Pattern

Held bySep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters54.39%54.39%54.39%54.39%54.39%
Flls0%0%0%0%0%
Dlls0%0%0%0%0%
Public45.61%45.61%45.61%45.61%45.61%

About Concord Drugs

CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.

Parent Organisation
Indian Private
Managing Director
S Nagi Reddy
Founded
1995
NSE Symbol

Concord Drugs Share Price History

Concord Drugs Share Price History

ParticularsDetails
5-Year % change in Concord Drugs share price77.99%
5-Year Highest in Concord Drugs share price₹ 61.5
5-Year Lowest in Concord Drugs share price₹ 12.65
1-Year % change in Concord Drugs share price-13.26%
1-Year Highest in Concord Drugs share price₹ 44.96
1-Year Lowest in Concord Drugs share price₹ 26.1

Top Mutual Funds Invested in Concord Drugs Share

Top Mutual Funds Invested in Concord Drugs Share

FUND NAMEAUM(%)

Peer Comparison

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,818.9
8.60 (0.48%)
₹4,34,159.661,548.0 - 1,910.0View Stocks
Divis Laboratories Ltd6,490.5
0.00 (0.00%)
₹1,72,287.784,955.0 - 7,071.5View Stocks
Torrent Pharmaceuticals Ltd3,719.6
-10.80 (-0.29%)
₹1,26,434.152,886.45 - 3,882.2View Stocks
Cipla Ltd1,525.8
0.60 (0.04%)
₹1,23,148.761,335.0 - 1,673.0View Stocks
Dr Reddys Laboratories Ltd1,246.5
-2.80 (-0.22%)
₹1,04,369.381,020.0 - 1,405.9View Stocks
Lupin Ltd2,080.6
9.20 (0.44%)
₹94,659.391,795.2 - 2,402.9View Stocks

Concord Drugs Ltd FAQs

Concord Drugs Ltd (Concord Drugs Ltd) share price as of November 28, 2025, on NSE is Rs 83.01 (NSE) and Rs 83.01 (BSE) on BSE.
Yes, You can buy Concord Drugs Ltd (Concord Drugs Ltd) shares by opening a Demat account with Angel One.
Concord Drugs Ltd (Concord Drugs Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Concord Drugs Ltd (Concord Drugs Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Concord Drugs Ltd (Concord Drugs Ltd) shares.
Open Free Demat Account!
Join our 3 Cr+ happy customers